Clinically, there is a strong indication that mutations in the Nav1.1 subunit of sodium channels are heavily involved in treatment-resistant seizures (i.e., Dravet syndrome [38]). Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.